Pediatric Microbiome Study With Children Now Approximately 8-10 Years Old.
- Conditions
- Healthy Volunteers
- Registration Number
- NCT03485755
- Lead Sponsor
- Johnson & Johnson Consumer Inc. (J&JCI)
- Brief Summary
Single site study involving Biological Mothers and their children approximately 8-10 years old to assess the predominant microflora and skin physiology.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 16
- Must be the biological mother of a child (approximately age 8-10 years) enrolled in the study
- All subjects are to have normal healthy skin and no presence of pre-existing or dormant dermatologic skin conditions;
- Willing to use only the provided cleansing product during the washout time period;
- Willing to refrain from topical product use on the skin for the duration of the study. Topical products that should not be used include moisturizers, lotions, sunscreens, oils, tanners;
- Willing to refrain from swimming, using hot tubs, excessive sun exposure or tanning beds during the course of this study;
- Presents with a skin condition that may influence the outcome of the study (specifically psoriasis, eczema, atopic dermatitis, cutaneous xerosis, erythema, active skin cancer) a
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Microbial Community Diversity for Children Day 1 Swabs will be collected from the volar forearm, forehead and cheek for analysis based on the Shannon Index
- Secondary Outcome Measures
Name Time Method Microbial Community Richness for Adults Day 1 swabs will be collected from the volar forearm, forehead and cheek for analysis to determine the total number of different bacterial taxa detected
Skin pH Day 1 skin pH will be assessed by pH meter
Microbial Community Diversity for Adults Day 1 swabs will be collected from the volar forearm, forehead and cheek for analysis based on the Shannon Index
Microbial Community Richness for Children Day 1 swabs will be collected from the skin for analysis to determine the total number of different bacterial taxa detected
Skin Barrier Function Day 1 Trans Epidermal Water Loss (TEWL) will be used to assess the skin barrier function
Trial Locations
- Locations (1)
Consumer Experience Center
🇺🇸Skillman, New Jersey, United States